Login to Your Account



Prequalification status issued for Shantha's pentavalent vaccine

By Cornelia Zou
Staff Writer

Friday, May 9, 2014
HONG KONG – Four years after it was sidelined, a pentavalent vaccine produced by the Indian arm of Sanofi Pasteur (the vaccine division of Sanofi SA) – Shantha Biotechnics Ltd. – received prequalification status from the World Health Organization.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription